Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1140 results for "fda"

CBS Health: FDA approves testing new Ebola drug
CBS News

Opinion: Ebola: What Is the FDA Hiding?

Goldwater Institute Political Consultant Starlee Coleman asks why federal bureaucrats granted Ebola patients special access to experimental drugs. Plus, Michigan passes a Right to Try NEWS.com.au, 2 hours ago
[x]  

6,854 images for fda

MassDevice, 2 hours ago
MassDevice, 5 hours ago
The Guardian Express, 2 days ago
MassDevice, 3 hours ago
windows.net, 1 hour ago
Mid Day, 1 day ago
MassDevice, 3 days ago
PRWeb, 11 hours ago
Rochester People, 1 hour ago
Mid Day, 1 day ago
Securities Technology Monitor

FDA advisory panel backs Novartis' secukinumab for plaque psoriasis

Novartis announced Monday that an FDA advisory committee voted unanimously in favour of recommending its selective IL-17A inhibitor secukinumab for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic ...
 FirstWord Pharma2 hours ago Novartis : announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis  4 Traders2 hours ago Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis  Yahoo! UK and Ireland2 hours ago
[x]  
MassDevice

FDA OKs Dexcom SHARE

Dexcom, Inc. (DXCM: Quote) said Monday that it has received U.S. Food and Drug Administration approval for its continuous glucose monitoring remote mobile communications device: Dexcom SHARE. Dexcom SHARE, an accessory to the Dexcom G4 PLATINUM ...
 RTTNews.com4 hours ago FDA clears communications device for Dexcom glucose monitoring system  Seeking Alpha6 hours ago FDA Approves Dexcom SHARE, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM)  BusinessWeek8 hours ago FDA approves Dexcom smartphone-enabled device for continuous glucose monitor  FierceMedicalDevices4 hours ago
[x]  
Reuters India

FDA panel unanimously backs Novartis' psoriasis drug

Oct 20 (Reuters) - An advisory panel to the U.S. Food and Drug Administration unanimously recommended the use of Novartis AG's anti-inflammation drug in patients with a type of psoriasis, paving the way for its approval. The panel voted 7-0 in ...
 CNBC3 hours ago Novartis clears an FDA hurdle with its pioneering psoriasis treatment  FierceBiotech2 hours ago FDA panel offers mixed view on Boston Scientific Watchman device  Reuters1 week ago U.S. FDA panel recommends approval of NPS hormone replacement drug  Reuters1 month ago
[x]  
The Guardian Express

Navidea's sNDA for expanded use of Lymphoseek injection receives FDA approval

Navidea Biopharmaceuticals, Inc. has received the FDA approval for the supplemental new drug application, or sNDA, for the expanded use of Lymphoseek injection for lymphatic mapping in solid tumors and adding Sentinel Lymph Node detection for breast ...
 Individual.com8 hours ago Genentech Garners FDA Approval of Esbriet for Idiopathic Pulmonary Fibrosis  Individual.com16 hours ago Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 60856) - Meeting  HispanicBusiness.com2 hours ago US FDA backs abuse deterrent labeling for Pfizer's Embeda ER  Pharma Letter9 hours ago
[x]  
Mobihealthnews

FDA clears military-tested PTSD, brain injury diagnostic app

Last week the FDA granted 510(k)clearance to a mobile-based cognitive test called DANA (Defense Automated Neurobehavioral Assessment), which helps healthcare providers better assess the medical or psychological state of their patients. DANA was ...
 Mobihealthnews4 hours ago FDA clears AnthroTronix mobile app for PTSD, brain trauma assessment  MassDevice4 hours ago AnthroTronix's brain health assessment tool obtains FDA approval  Medical Devices Business Review3 days ago 10/19/14 - AnthroTronix Receives FDA Clearance for Brain Health Assessment Tool [EMBIN (Emerging Markets Business Information News]  Pharmacy Choice1 day ago
[x]  

OctreoPharm receives orphan drug status from FDA for tumor diagnostic agent

OctreoPharm Sciences GmbH, a biopharmaceutical company, has received an orphan drug status from the FDA for its new tumor diagnostic agent, SOMscan. The European Medicines Agency EMA already awarded SOMscan orphan drug status at the beginning of ...
 Individual.com6 hours ago Amarantus Bioscience Holdings Inc applies to FDA for MANF Orphan Drug Designation in Retinitis Pigmentosa  Reuters UK3 days ago Eckert & Ziegler Strahlen und Medizintechnik AG says SOMscan receives orphan drug status from FDA  Reuters UK3 days ago OctreoPharm Sciences obtient la désignation de médicament orphelin de la FDA pour la gestion des tumeurs neuroendocrines  Business Wire3 days ago
[x]  

Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant

Halozyme Therapeutics, Inc. (MM) (NASDAQ:HALO) Intraday Stock Chart Today : Monday 20 October 2014 SAN DIEGO , Oct. 20, 2014 /PRNewswire/ --Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration ...
 ADVFN India9 hours ago 10/20/14 - Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant  Pharmacy Choice2 hours ago Halozyme Therapeutics, Inc. Receives FDA Approval For Additional Manufacturing Facilities For Hylenex?? Recombinant  BioSpace5 hours ago HALOZYME THERAPEUTICS : Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant  4 Traders9 hours ago
[x]  
Medical Design Online

FDA Invites Participation In Pilot 510(k) eSubmission Program

By , Ph.D. A pilot program for the electronic submission of 510(k) documents is being expanded after a successful initial test period. The online process has been likened to commercial tax software and promises to increase ease of use for ...
 Medical Design Online6 hours ago

Actavis files ANDA for attention deficit hyperactivity disorder drug with FDA

Actavis plc, a generic drug company, has filed an abbreviated new drug application, or ANDA, with the FDA seeking approval to market Methylphenidate Hydrochloride for extended-release oral suspension, 5mg/mL for treatment of attention deficit ...
 Individual.com6 hours ago Actavis seeks FDA approval to market Methylphenidate Hydrochloride 5mg/mL  Pharmaceutical Business Review3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - fda
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less